Fungal infections in transplant recipients

European Respiratory Journal

Volumn 17, Issue 1, 2001, Pages 133-140

  Nicod L P, ^a   Pache, J C ^a   Howarth, N ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Fungal infections; Immunosuppression; Opportunistic infections; Prophylaxis; Transplantation; Treatment

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; KETOCONAZOLE; PHENYTOIN; PYRROLE DERIVATIVE; RIFAMPICIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; BONE MARROW TRANSPLANTATION; BRONCHOPULMONARY ASPERGILLOMA; CANDIDIASIS; CONTROLLED STUDY; CRYPTOCOCCOSIS; FUNGUS CULTURE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LUNG ASPERGILLOSIS; LUNG MYCOSIS; MUCORMYCOSIS; NEPHROTOXICITY; NEUTROPENIA; OPPORTUNISTIC INFECTION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; TRANSPLANTATION;

HUMANS; IMMUNOCOMPROMISED HOST; LUNG; LUNG DISEASES, FUNGAL; OPPORTUNISTIC INFECTIONS; ORGAN TRANSPLANTATION;

EID: 0034958833     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.01.17101330     Document Type: Article

References (63)

1. Opportunistic fungal pneumonia
2. Infection after lung transplantation
3. Infectious complications following isolated lung transplantation
4. Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis
5. Common infections complicating lung transplantation
6. Preemptive therapy with azoles in lung transplant patients
7. The independent role of cytomegalovirus as a risk factor for invasive fungal disease in orthotopic liver transplant recipients
8. Infections in liver transplant recipients
9. Infectious complications following renal transplantation
10. Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer
11. Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients
12. Pulmonary complications after bone marrow transplantation: High-resolution CT and pathologic findings
13. Invasive Aspergillosis clinical features of 35 proven cases at a single institution
14. Recurrence of allergic bronchopulmonary aspergillosis in the post-transplant lungs of a cystic fibrosis patient
15. Diagnosis and management of invasive aspergillosis
16. Pathogenesis of pulmonary aspergillosis granulocytopenia versus cyclosporine and methylprednisone-induced immunosuppression
17. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: Results of a 5 year retrospective study
18. Incidence and significance of Aspergillus cultures following liver and kidney transplantation
19. Invasive aspergillosis in liver transplant recipients in the 1990s
20. Transbronchial biopsy in heart and lung transplantation: Clinicopathologic correlations
21. Open lung biopsy provides a higher and more specific diagnostic yield compared to broncho-alveolar lavage in immunocompromised patients
22. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery
23. Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature
24. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients
25. Thoracic manifestations of aspergillosis
26. Invasive pulmonary aspergillosis and acute leukemia: Characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis
27. Aspergillus infection of the respiratory tract after lung transplantation: Chest radiographic and CT findings
28. Invasive aspergillosis of the airways: Radiographic, CT, and pathologic findings
29. Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS
30. Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein
31. Fungal infections in patients undergoing bone marrow transplantation: An approach to a rational management protocol
32. Candida Species Pneumonia
33. Opportunistic Fungal Pneumonias: Aspergillus, Mucor, Candida, Torulopsis
34. Candida albicans pneumonia: Radiographic appearance
35. Pulmonary candidiasis in infants: Clinical, radiologic, and pathologic features
36. Acute pulmonary mycetoma due to Candida albicans with complete resolution
37. Mucormycosis
38. Torulopsis glabrata pneumonitis in patients with cancer: Report of three cases
39. The new fungal opportunists are coming
40. Clinical patterns of Fusarium infections in immunocompromised patients
41. Thoracic cryptococcosis: Immunologic competence and radiographic appearance
42. Pulmonary cryptococcosis
43. Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients
44. Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin
45. Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: A single-centre experience of 133 episodes in 116 patients
46. Am Bisome targeting to fungal infections
47. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy
48. Hepatosplenic candidiasis: Successful treatment with fluconazole
49. Activity of voriconazole against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis
50. The efficacy of itraconazole against systemic fungal infections in neutropenic patients: A randomised comparative study with amphotericin B
51. Treatment of invasive aspergillosis with itraconazole
52. European experience with itraconazole in systemic mycoses
53. Itraconazole for the of pulmonary aspergillosis in heart transplant recipients
54. Modulation of neutrophil-mediated activity against the pseudohyphal form of Candida albicans by granulocyte colony-stimulating factor (G-CSF) administered in vivo
55. Saprophytic fungal infections and lung transplantation - Revisited
56. Lung transplantation
57. Antifungal prophylaxis during early postoperative period of lung transplantation
58. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
59. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation. A prospective, randomized, double blind study
60. Coadministration of ketoconazole to cyclosporin-treated kidney transplant recipients: A prospective randomized study
61. Fungal complications of transplantation: Diagnosis, treatment and prevention
62. Itraconazole resistance in Aspergillus fumigatus
63. Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: A review and recommendations